Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

73

Targeted degradation of oncogenic KRAS G12V triggers antitumor immunity in lung cancer models

Tags:

Previous Article

Increased cholesterol synthesis drives neurotoxicity in multiple sclerosis

Animal model for antitumor immunity in lung cancer

Related Posts

The bleeding edge: broadening horizons for hematopoietic stem cell therapies

The bleeding edge: broadening horizons for hematopoieti...

68

Mitochondrial origins of the pressure to sleep

Mitochondrial origins of the pressure to sleep

143

Single-cell profiling reveals a conserved role for hypoxia-inducible factor signaling during human craniotomy infection

Single-cell profiling reveals a conserved role for hypo...

92